3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
4
Breast Neoplasms
4
Liver Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Carcinoma, Non-Small-Cell Lung
2
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pain
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Melanoma
1
Malignant Pleural Neoplasm
1
Lung Neoplasms
1
Localised Prostate Cancer
1
Leiomyoma
1
Ileus
1
Hordeolum
1
Glioblastoma
1
Eyelid Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Lidocaine
×
1 year
×
Clear all
No trials found.